Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. USA & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1. Compounding Pharmaceuticals Market, by Product Type, 2018-2027 (USD Billion)
1.2.2. Compounding Pharmaceuticals Market, by Therapeutic area, 2018-2027 (USD Billion)
1.2.3. Compounding Pharmaceuticals Market, by Distribution Channel, 2018-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. USA Compounding Pharmaceuticals Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. USA Compounding Pharmaceuticals Market Dynamics
3.1. Compounding Pharmaceuticals Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. USA Compounding Pharmaceuticals Market: Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2017-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. USA Compounding Pharmaceuticals Market, by Product Type
5.1. Market Snapshot
5.2. USA Compounding Pharmaceuticals Market by Product Type, Performance – Potential Analysis
5.3. USA Compounding Pharmaceuticals Market Estimates & Forecasts by Product Type 2017-2027 (USD Billion)
5.4. Compounding Pharmaceuticals Market, Sub Segment Analysis
5.4.1. Oral medications
5.4.2. Topical medications
5.4.3. Suppositories
5.4.4. Others
Chapter 6. USA Compounding Pharmaceuticals Market, by Therapeutic area
6.1. Market Snapshot
6.2. USA Compounding Pharmaceuticals Market by Therapeutic area, Performance – Potential Analysis
6.3. USA Compounding Pharmaceuticals Market Estimates & Forecasts by Therapeutic area 2017-2027 (USD Billion)
6.4. Compounding Pharmaceuticals Market, Sub Segment Analysis
6.4.1. Pain medications
6.4.2. Hormone replacement therapies
6.4.3. Dermatological applications
6.4.4. Others
Chapter 7. USA Compounding Pharmaceuticals Market, by Distribution channel
7.1. Market Snapshot
7.2. USA Compounding Pharmaceuticals Market by Distribution channel, Performance – Potential Analysis
7.3. USA Compounding Pharmaceuticals Market Estimates & Forecasts by Distribution channel 2017-2027 (USD Billion)
7.4. Compounding Pharmaceuticals Market, Sub Segment Analysis
7.4.1. Compounding pharmacies
7.4.2. Traditional stores
Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. Fagron
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Type Summary
8.2.1.5. Recent Developments
8.2.2. Institutional pharmacy solutions
8.2.3. B.Braun Melsungen AG Company
8.2.4. Athenex pharma solution
8.2.5. Nephron pharmaceuticals corporation
8.2.6. Triangle compounding pharmacy
8.2.7. Fresenius Kabi AG
8.2.8. Rx3 compounding pharmacy
8.2.9. Clinigen group Plc
8.2.10. Pencol compounding pharmacy
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption
TABLE 1. USA Compounding Pharmaceuticals market estimates & forecasts by Product Type 2017-2027 (USD Billion)
TABLE 2. USA Compounding Pharmaceuticals market estimates & forecasts by Therapeutic area 2017-2027 (USD Billion)
TABLE 3. USA Compounding Pharmaceuticals market estimates & forecasts by Application 2017-2027 (USD Billion)
TABLE 4. USA Compounding Pharmaceuticals market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 5. USA Compounding Pharmaceuticals market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 6. USA Compounding Pharmaceuticals market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 7. USA Compounding Pharmaceuticals market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 8. USA Compounding Pharmaceuticals market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 9. USA Compounding Pharmaceuticals market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 10. USA Compounding Pharmaceuticals market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 11. USA Compounding Pharmaceuticals market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 12. USA Compounding Pharmaceuticals market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 13. USA Compounding Pharmaceuticals market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 14. USA Compounding Pharmaceuticals market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 15. USA Compounding Pharmaceuticals market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 16. USA Compounding Pharmaceuticals market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 17. USA Compounding Pharmaceuticals market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 18. USA Compounding Pharmaceuticals market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 19. USA Compounding Pharmaceuticals market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 20. Years considered for the study
TABLE 21. Exchange rates considered
List of figures
FIG 1. USA Compounding Pharmaceuticals market, research methodology
FIG 2. USA Compounding Pharmaceuticals market, market estimation techniques
FIG 3. USA market size estimates & forecast methods
FIG 4. USA Compounding Pharmaceuticals market, key trends 2019
FIG 5. USA Compounding Pharmaceuticals market, growth prospects 2020-2027
FIG 6. USA Compounding Pharmaceuticals market, porters 5 force model
FIG 7. USA Compounding Pharmaceuticals market, pest analysis
FIG 8. USA Compounding Pharmaceuticals market, value chain analysis
FIG 9. USA Compounding Pharmaceuticals market by segment, 2017 & 2027 (USD Billion)
FIG 10. USA Compounding Pharmaceuticals market by segment, 2017 & 2027 (USD Billion)
FIG 11. USA Compounding Pharmaceuticals market by segment, 2017 & 2027 (USD Billion)
FIG 12. USA Compounding Pharmaceuticals market by segment, 2017 & 2027 (USD Billion)
FIG 13. USA Compounding Pharmaceuticals market by segment, 2017 & 2027 (USD Billion)
FIG 14. USA Compounding Pharmaceuticals market by segment, 2017 & 2027 (USD Billion)
FIG 15. USA Compounding Pharmaceuticals market by segment, 2017 & 2027 (USD Billion)
FIG 16. USA Compounding Pharmaceuticals market by segment, 2017 & 2027 (USD Billion)